🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

GBE Deficiency (GSD IV and APBD) Natural History Study

Recruitingn/aAges 0 Years - 90 YearsAllDuke University
NCT02683512 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Collection and review of clinical information related to glycogen branching enzyme (GBE) deficiency, diagnosed as Glycogen Storage Disease Type IV (GSD IV) or Adult Polyglucosan Body Disease (APBD generated during clinic visits.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
* Diagnosis of GSD IV or APBD via: * Two variants in the GBE1 gene * Deficient GBE activity in liver, muscle, skin fibroblast or other tissue * One variant in GBE1 gene with evidence of disease that is pathogenic, per the clinician * Able to provide informed consent for self (adults) or affected individual (minor or adults with a legally authorized representative) * Able to provide consent for release of medical records * Pregnant women with a diagnosis of GSD IV or APBD will be included * Histology as confirmed by clinician
💊

What it tests

  • No intervention
📍

Where

1 site
Duke University Medical Center
Durham, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy